NCT04776031View on ClinicalTrials.gov

Evaluation of R:GEN as Intervention in Subjects With Early Stages of AMD for Safety and Exploratory Efficacy Outcomes

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

February 15, 2021

Primary Completion Date

March 14, 2023

Study Completion Date

March 14, 2023

Conditions
Early Age Related Macular Degeneration (Disorder)
Interventions
DEVICE

R:GEN Laser System

Laser Treatment

Trial Locations (1)

3002

Centre for Eye Research Australia - Royal Victorian Eye & Ear Hospital, East Melbourne

Sponsors
All Listed Sponsors
collaborator

Neuroscience Trials Australia

OTHER

lead

Lutronic Vision, Inc

INDUSTRY

NCT04776031 - Evaluation of R:GEN as Intervention in Subjects With Early Stages of AMD for Safety and Exploratory Efficacy Outcomes | Biotech Hunter | Biotech Hunter